Home LiteratureArticle Details
PMID: 14599554 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells.

Biochemical pharmacology ·Vol. 66 ·No. 10 ·2003-11-15 ·Pages 1963-71

Cahuana GM, Tejedo JR, Jiménez J, Ramírez R, Sobrino F, Bedoya FJ

Abstract

We have explored the impact of nitric oxide (NO) exposure on oxidation damage of lipids, and proteins, and the contribution of this type of damage to the activation of the apoptotic program in insulin secreting RINm5F cells. Exposure of cells to NO donors and to interleukin-1 beta (IL-1beta) led to generation of lipooxidation products such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). Addition of superoxide dismutase (SOD) and catalase (Cat) to cells decreased by 50% MDA and 4-HNE production induced by IL-1beta. Over-expression of Mn-SOD in cells conferred a remarkable decrease (75%) in IL-1beta-induced lipid peroxidation. These data suggest that peroxynitrite (ONOO(-)) mediates peroxidative damage to lipids in this cell system. Inhibitors of advanced lipooxidation end products (ALEs) formation such as aminoguanidine (AG) and pyridoxamine (PM) prevented partially apoptotic events triggered by NO such as DNA fragmentation, caspase-3 activation and cytochrome c release from mitochondria. These findings indicate that ALEs are involved in NO-induced apoptosis. In fact, NO-induced carbonylation of PARP protein preceded its apoptotic degradation and inhibitors of ALEs formation prevented both events. We thus propose that carbonylation of proteins is instrumental in linking NO-dependent lipid oxidation and apoptosis in this cell system.

MeSH Terms
Animals Apoptosis Cells, Cultured DNA Fragmentation/drug effects Insulin/metabolism Insulin Secretion Interleukin-1/pharmacology L-Lactate Dehydrogenase/metabolism Lipid Peroxidation/drug effects Nitric Oxide/pharmacology Oxidation-Reduction/drug effects Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerases Proteins/metabolism Rats Superoxide Dismutase/metabolism
Chemicals
Insulin Interleukin-1 Proteins Nitric Oxide L-Lactate Dehydrogenase Superoxide Dismutase Parp1 protein, rat Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Cahuana Gladys M
Department of Medical Biochemistry and Molecular Biology, University of Sevilla, Avenida Sanchez Pizjuan 4, 41009 Sevilla, Spain.
Tejedo Juan R
Jiménez Juan
Ramírez Remedios
Sobrino Francisco
Bedoya Francisco J
Article Info
Journal
Biochemical pharmacology
Abbr.
Biochem Pharmacol
ISSN
0006-2952
Published
2003-11-15
Pages
1963-71
Language
English
Region
England
NLM ID
0101032
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]